Data on gene therapy for IBMFS start to emerge, for DBA a RPS19 deficient CD34+ HSPC model was established using nanostraws in which EFS-RPS19 they used to restore erythroid differentiation and enhance erythropoiesis. This evidence concerns the gene RPS19 and Diamond-Blackfan anemia.